Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TNXP Tonix Pharmaceuticals Holding Corp. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $9.31 -4.4% | $15.90 -2.5% |
| StockIQ Score | 42D Weak Risk: High | 41D Weak Risk: High |
| Technical | 6F | 36F |
| Fundamental | 35F | 35F |
| Growth | 62C+ | 50C- |
| Fair Value | 55C | 38F |
| News | 86A | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Tonix Pharmaceuticals (TNXP) outperforms Ascentage Pharma (AAPG) in growth (62 vs. 50) and valuation (55 vs. 38), showing stronger potential for expansion and pricing relative to earnings. However, AAPG has a slightly better technical score (36 vs. 6), indicating more favorable short-term trading conditions. Both stocks share a weak rating and equal fundamental scores (35).
